 GERMANTOWN, Md,, June 10, 2021 PRNewswire -- Precigen, Inc. Nasdaq: PGEN, a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will participate in a fireside chat at the annual JMP Securities Life Sciences Conference on Thursday, June 17, 2021 at 11:00 AM ET. Participants may access the live webcasts of the virtual events through Precigens website in the Events Presentations section at investors.precigen.comevents-presentations. 